References

  1. Marine Panaye, Anne Jolivot Sandrine Lemoine, Fitsum Guebre-Egziabher, Muriel Doret, Emmanuel Morelon, Laurent Juillard. Pregnancies in hemodialysis and in patients with end-stage chronic kidney disease: epidemiology, management and prognosis. Néphrologie & Thérapeutique. 2014; 10(7): 485-491. PubMed | Google Scholar

  2. Marie-Claire Gubler, Laurence Heidet, Corinne Antignac. Syndrome d'alport ou néphropathie héréditaire hématurique progressive avec surdité. Néphrologie & Thérapeutique. 2007; 3(3): 113-120. Google Scholar

  3. Gubler MC, Heidet L, Antignac C. Alport's syndrome, thin basement membrane nephropathy, nail patella syndrome and type III collagen glomerulopathy: In: Jennette JC, Olson JL, Schwartz MM, Silva FG, editors. Heptinstall's Pathology of the Kidney, 6th ed Philadelphia Lippincott Williams & Wilkins Publishers. 2007; 496-515.

  4. Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A et al. X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a « European Community Alport's syndrome Concerted Action Study ». J Am Soc Nephrol. 2003; 14(10): 2603-13. PubMed | Google Scholar

  5. Bar J, Ben-Rafael Z, Padoa A et al. Prediction of pregnancy outcome in subgroups of women with renal disease. Clin Nephrol. 2000; 53(6): 437-44. PubMed | Google Scholar

  6. Joy Weyricha, Anna Settera B, Alexander Müllerc, Georg Schmidtc, Christine E, Brambsa, Javier U, Ortiza, Silvia M. Lobmaiera Longitudinal progression of fetal short-term variation and average acceleration and deceleration capacity after antenatal maternal betamethasone application. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2017; 212: 85-90. PubMed | Google Scholar

  7. Jungers P. Néphropathie et grossesse. EMC-Medecine. 2004; 1: 121-130. Google Scholar